Skip to main content

Table 4 Cause-specific mortality in IgA anti-tTG positive individuals

From: Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III

Follow-up

tTGA+ Deaths

tTGA- Deaths

Adjusted HR; 95 % CI

P value

Absolute risk/1000 PYAR

Excess risk/1000 PYAR

Cardiovascular

21

1372

1.10; 0.72–1.70

0.653

27

2

Cancer

13

662

1.48; 0.85–2.56

0.164

16

5

Respiratory

11

180

5.11; 2.76–9.46

<0.001

14

11

Other

13

743

1.30; 0.75–2.25

0.351

16

4

  1. Reference is general population comparator cohort
  2. tTGA tissue transglutaminase antibody, PYAR Person-years at risk